Perhexilene maleate in treatment of angina pectoris.
D000787:Angina Pectoris / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight; D002302:Cardiac Output / Q000187:drug effects; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004231:Diuresis / Q000187:drug effects; D004361:Drug Tolerance; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008298:Maleates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009206:Myocardium / Q000378:metabolism; D005996:Nitroglycerin / Q000627:therapeutic use; D010101:Oxygen Consumption / Q000187:drug effects; D005082:Physical Exertion / Q000187:drug effects; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011141:Polyuria / Q000139:chemically induced; D012146:Rest
D003510:Cyclohexanes; D008298:Maleates; D010880:Piperidines; D010919:Placebos; D005996:Nitroglycerin